Literature DB >> 27611337

Novel technology for liver regeneration and replacement.

Jason A Wertheim1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27611337      PMCID： PMC5244428          DOI： 10.1002/lt.24635

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  40 in total

1.  Dual-Purpose Bioreactors to Monitor Noninvasive Physical and Biochemical Markers of Kidney and Liver Scaffold Recellularization.

Authors:  Joseph S Uzarski; Brent M Bijonowski; Bo Wang; Heather H Ward; Angela Wandinger-Ness; William M Miller; Jason A Wertheim
Journal:  Tissue Eng Part C Methods       Date:  2015-06-26       Impact factor: 3.056

Review 2.  Cellular therapy and bioartificial approaches to liver replacement.

Authors:  Jason A Wertheim; Pedro M Baptista; Alejandro Soto-Gutierrez
Journal:  Curr Opin Organ Transplant       Date:  2012-06       Impact factor: 2.640

3.  Immunogenicity of induced pluripotent stem cells.

Authors:  Tongbiao Zhao; Zhen-Ning Zhang; Zhili Rong; Yang Xu
Journal:  Nature       Date:  2011-05-13       Impact factor: 49.962

4.  Adult hepatocytes are generated by self-duplication rather than stem cell differentiation.

Authors:  Kilangsungla Yanger; David Knigin; Yiwei Zong; Lara Maggs; Guoqiang Gu; Haruhiko Akiyama; Eli Pikarsky; Ben Z Stanger
Journal:  Cell Stem Cell       Date:  2014-08-14       Impact factor: 24.633

5.  Enhancing the functional maturity of induced pluripotent stem cell-derived human hepatocytes by controlled presentation of cell-cell interactions in vitro.

Authors:  Dustin R Berger; Brenton R Ware; Matthew D Davidson; Samuel R Allsup; Salman R Khetani
Journal:  Hepatology       Date:  2015-04       Impact factor: 17.425

6.  Hypothermic machine preservation in human liver transplantation: the first clinical series.

Authors:  J V Guarrera; S D Henry; B Samstein; R Odeh-Ramadan; M Kinkhabwala; M J Goldstein; L E Ratner; J F Renz; H T Lee; R S Brown; J C Emond
Journal:  Am J Transplant       Date:  2009-12-02       Impact factor: 8.086

7.  Ex Vivo Perfusion Treatment of Infection in Human Donor Lungs.

Authors:  D Nakajima; M Cypel; R Bonato; T N Machuca; I Iskender; K Hashimoto; V Linacre; M Chen; R Coutinho; S Azad; T Martinu; T K Waddell; D M Hwang; S Husain; M Liu; S Keshavjee
Journal:  Am J Transplant       Date:  2016-01-05       Impact factor: 8.086

8.  Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo.

Authors:  Deepak Nagrath; Hongzhi Xu; Yoko Tanimura; Rongjun Zuo; François Berthiaume; Marco Avila; Rubin Yarmush; Martin L Yarmush
Journal:  Metab Eng       Date:  2009-06-07       Impact factor: 9.783

9.  Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.

Authors:  Ryoko Araki; Masahiro Uda; Yuko Hoki; Misato Sunayama; Miki Nakamura; Shunsuke Ando; Mayumi Sugiura; Hisashi Ideno; Akemi Shimada; Akira Nifuji; Masumi Abe
Journal:  Nature       Date:  2013-01-09       Impact factor: 49.962

10.  Human-scale whole-organ bioengineering for liver transplantation: a regenerative medicine approach.

Authors:  Hiroshi Yagi; Ken Fukumitsu; Kazumasa Fukuda; Minoru Kitago; Masahiro Shinoda; Hideaki Obara; Osamu Itano; Shigeyuki Kawachi; Minoru Tanabe; Gina M Coudriet; Jon D Piganelli; Thomas W Gilbert; Alejandro Soto-Gutierrez; Yuko Kitagawa
Journal:  Cell Transplant       Date:  2012-08-27       Impact factor: 4.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.